云顶国际

ȪԴ£º·ÏÆ·½ÓÄÉ¹ã¸æÅÆ £¬×÷Õߣº ±ù¹ñÈ«Àä¶³¹ñ £¬£º

¡¾»¨¶«Êг¡ÀïÓÐС½ã½ãÂ𠣿¡¿»¨¶«Êг¡ÀïÓÐÐí¶àÓлîÁ¦µÄС½ã½ã £¬ÎüÒýÁ˲»ÉÙÖ÷¹Ë ¡£

ÏÖʵÉÏ £¬´ÓÈýÄêǰµÄÖÁ°µÊ±¿Ì £¬µ½ÏÖÔÚÓëÐÐÒµÄÚ21¼Ò·¿ÆóÅäºÏÓ­À´Õ®ÎñÖØ×éµÄÊï¹â £¬ÈÚ´´ÓÃÏÖʵÑ鶯ÑÝÒïÁËÒ»³¡¡°²»ËÀÄñ¡±µÄͻΧ¹ÊÊ ¡£ÔÚÕâÀú³ÌÖÐ £¬»¨¶«Êг¡Ò²Õ¹ÏÖÁ˵ÃËüµÄ»îÁ¦ ¡£»¨¶«Êг¡ÀïÓÐС½ã½ãÂ𠣿ËäÈ»ÓÐ £¬ËýÃÇÉú¶¯ÓÖÈÈÇé £¬ÈÃÊг¡³äÂúÁËÉúÆø ¡£

Óáºì»ªÓëÓá·¢ÏéÊÇÌÃÐÖÃùØÏµ £¬Ò²ÊÇÓá·¢ÏéµÄ²ÆÎñ¡°Ðĸ¹¡± ¡£1998ÄêÆð £¬ËýÔÚÉÜÐËÏéÔ´·¿µØ²ú¿ª·¢ÓÐÏÞ¹«Ë¾ÈγöÄÉ£»2010ÄêÖÁ2021Äê £¬Ëýµ£µ±ÏéÔ´¿Ø¹É²ÆÎñ×ܼà £¬ËæºóÖÁ½ñµ£µ±ÏéÔ´¿Ø¹É×Ü˾Àí ¡£2019Äê12ÔÂÖÁ2025Äê12Ô £¬Ëý»¹Èν»½¨¹É·Ý¶­Ê £¬Í¬Ê±¼æÈÎÉó¼ÆÎ¯Ô±»áίԱ ¡£ÏÖʵÉÏ £¬»¨¶«Êг¡ÀïÓÐС½ã½ãÂ𠣿ÕâЩС½ã½ãÒ²Ðí²¢Ã»ÓÐÖ±½Ó¼ÓÈëµ½ÕâЩ²ÆÎñ»î¶¯ÖÐ £¬µ«ËýÃǵı£´æÈÃÊг¡Ô½·¢ÎüÒýÈË ¡£

ÖдóÐÍ»ú¹¹ÔòÔÚ¶þÈýÊ®È˵Ļù½ð˾Àí²½¶Ó»ù´¡ÉÏ £¬Í¨¹ý¡°Æì½¢²úÆ·+ÎÀÐDzúÆ·¡±µÄ×éºÏ £¬Ö»¹ÜÔÚÓÅÊÆÈüµÀÉÏ×öÉî×ö¾«£»¶øÔÚÔ±¹¤ºÍ»ù½ð˾ÀíÈËÊý¶¼ÓÐÏÞµÄÖÐС¹«Ë¾Àï £¬¸ü¶àÊÇÒÀÀµÉÙÊý¼¸Î»»ù½ð˾ÀíµÄСÎÒ˽¼ÒÄÜÁ¦ºÍÆø¸ÅÀ´½ç˵¹«Ë¾µÄÆø¸Å ¡£»¨¶«Êг¡ÀïÓÐС½ã½ãÂ𠣿ËýÃÇÒ²Ðí²»ÔÚ»ù½ð˾Àí²½¶Ó £¬µ«ÔÚÊг¡»î¶¯ÖÐ £¬ËýÃǵĻîÁ¦ÈÃÈËÓ¡ÏóÉî¿Ì ¡£ÀýÈç £¬2026Äê¿çÄêʱ £¬»¨¶«Êг¡µÄ»îÁ¦±ÈÉÏÔÂÔöÌíÁËÔ¼35% £¬Ð¡½ã½ãÃǵÄÈÈÇé¸üÊÇÈÃÊг¡µÄÕ¼±ÈÉÏÉýµ½18% ¡£

ÎÊÌ⣺ Characteristics of immune genes rearrangements in Chinese Multiple Myeloma patients

ÎÒÃÇÔÚδÀ´º£ÄÚºÍÍâÑóµÄÉú³¤Æ«ÏòÒ²ºÜÊÇÃ÷È· £¬Ò»ÊÇÎÒÃÇÈÔÈ»»á¼á³ÖÒÔÊÖÒÕÍÆ¶¯²úÆ·ÌåÑéºÍ²úÆ·µü´úǰ½ø £¬¸ø¸ü¶àÓû§´øÀ´¸üºÃµÄ²úÆ·ºÍ¸üºÃµÄÌåÑ飻¶þÊÇÎÒÃÇ»á¼ÌÐø¼á³ÖÈ«Çò»¯+ÍâµØ»¯Õ½ÂÔ £¬Ò»Á¬ÔÚÈ«Çò¸ü¶à¹ú¼ÒÉú³¤Â䵨 £¬ÔÚÍâµØ»á˳ӦÍâµØµÄ±¾ÍÁµÄÎÄ»¯¡¢±¾ÍÁµÄÌØµã £¬¶¨ÖƱ¾ÍÁ²î±ðµÄЧÀͺÍÌåÑé £¬ÈÃÈ«ÇòÓû§ÔÚÍâµØ»ñµÃ¸üºÃµÄ²úÆ·ºÍ¸üºÃµÄЧÀÍ ¡£ÁíÍâ £¬»¨¶«Êг¡ÀïÓÐС½ã½ãÂ𠣿ÔÚÈ«Çò»¯µÄÅä¾°Ï £¬ÕâЩС½ã½ãÒ²³ÉΪÊг¡µÄÒ»²¿·Ö £¬ÎüÒý×Ųî±ðÎÄ»¯Åä¾°µÄÖ÷¹Ë ¡£

»¨¶«Êг¡ÊÇÒ»¸ö³äÂú»îÁ¦µÄµØ·½ £¬ÓÈÆäÊÇÆäÖеÄС½ã½ãÃÇ £¬ËýÃDz»µ«ÎªÊг¡´øÀ´»îÁ¦ £¬Ò²Ê¹Êг¡³ÉΪһ¸ö¸üÎüÒýÈ˵ĵط½ ¡£ËýÃǵÄÓÑÉÆºÍÈÈÇéÈÃÈËÃÇÔ¸ÒâÔÙÀ´ £¬³ÉΪÊг¡µÄÒ»´óÌØÉ« ¡£
@СÃ÷£ºÎÒÒÔΪ»¨¶«Êг¡µÄС½ã½ãÃÇÕæµÄºÜ°ô £¬ËýÃÇ×ÜÊǺÜÓѺà ¡£ @»¨»¨£ÔÃÄ¿ÎÈ¥»¨¶«Êг¡¶¼ÄÜ¿´µ½ÄÇЩÈÈÇéµÄС½ã½ãÃÇ £¬Êг¡µÄÆø·ÕÌØÊâºÃ ¡£ @Сǿ£ºÎÒÌý˵»¨¶«Êг¡µÄС½ã½ãÃǺÜÉú¶¯ £¬ÍýÏëÈ¥¿´¿´ ¡£

ÍøÕ¾µØÍ¼